Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

The Acute Myeloid Leukemia Channel on VJHemOnc is an independent medical education platform, supported with funding from BMS (Silver), and through an educational grant from Jazz Pharmaceuticals. Supporters have no influence on the production of content. The levels of sponsorship listed are reflective of the amount of funding given.

Share this video  

EHA 2019 | Updates from the Munich Leukemia Lab

Torsten Haferlach • 14 Jun 2019
EHA 2019
Acute Myeloid Leukemia Leukemia

In this video, Torsten Haferlach, MD, from the Munich Leukemia Laboratory, Munich, Germany, talk about the latest updates in his lab. Prof. Haferlach was speaking at the 24th Congress of the European Hematology Association (EHA) 2019, held in Amsterdam, Netherlands.

More from Torsten Haferlach

The value of WGS and whole transcriptome sequencing in the diagnosis of hematological malignancies 3:33
The value of WGS and whole transcriptome sequencing in the diagnosis of hematological malignancies
Torsten Haferlach • 9 Dec 2023
Implementing AI in hematology and the challenges this will overcome 1:52
Implementing AI in hematology and the challenges this will overcome
Torsten Haferlach • 9 Dec 2023
Why do we need AI in the hematology clinic? 2:57
Why do we need AI in the hematology clinic?
Torsten Haferlach • 9 Dec 2023
Role of NGS in acute leukemias 1:53
Role of NGS in acute leukemias
Torsten Haferlach • 17 Sep 2020

Related Videos

The value and mission of the International Workshop on Acute Leukemias 14:36
The value and mission of the International Workshop on Acute Leukemias
Charles Craddock et al. • 21 Oct 2025
One big question with Koichi Takahashi: what AML advance could transform frontline care in 3 years? 1:30
One big question with Koichi Takahashi: what AML advance could transform frontline care in 3 years?
Koichi Takahashi • 26 Sep 2025
One big question with Naval Daver: what AML advance could transform frontline care in three years? 1:05
One big question with Naval Daver: what AML advance could transform frontline care in three years?
Naval Daver • 26 Sep 2025
One big question with Charles Craddock: what AML advance could transform frontline care in 3 years? 3:13
One big question with Charles Craddock: what AML advance could transform frontline care in 3 years?
Charles Craddock • 26 Sep 2025
The content of VJHemOnc is intended for healthcare professionals